Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
67184
Strengths
Irinotecan hydrochloride 20 mg/mL; Bumetanide .25 mg/mL; Amikacin sulfate 250 mg/mL; Oxaliplatin 50 mg/10mL; Oxaliplatin 100 mg/20mL; Olanzapine 10 mg/2mL; Nicardipine hydrochloride 2.5 mg/mL; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Ganirelix acetate 250 ug/.5mL; Micafungin 10 mg/mL; Micafungin 20 mg/mL; Icosapent ethyl 1 g/1; Hydroxyurea 500 mg/1; Gefitinib 250 mg/1; Imatinib mesylate 100 mg/1; Imatinib mesylate 400 mg/1; Pemetrexed disodium hemipentahydrate 100 mg/4mL; Pemetrexed disodium hemipentahydrate 500 mg/20mL; Bortezomib 3.5 mg/1
Dosage forms
Injection, Solution, Injection, Powder, Lyophilized, For solution, Injection, Powder, For solution, Tablet, Tablet, Film coated, Injection, Tablet, Film coated, Extended release, Capsule, Kit, Tablet, Coated
Routes
Intravenous, Oral, Intramuscular, Subcutaneous
Drug classes (FDA established)
Cephalosporin Antibacterial, Atypical Antipsychotic, Platinum-based Drug, Phosphodiesterase 5 Inhibitor, Kinase Inhibitor, Serotonin-3 Receptor Antagonist, Topoisomerase Inhibitor, beta3-Adrenergic Agonist, Echinocandin Antifungal, Loop Diuretic, Aminoglycoside Antibacterial, Folate Analog Metabolic Inhibitor, Dihydropyridine Calcium Channel Blocker, Gonadotropin Releasing Hormone Receptor Antagonist, Antimetabolite, Proteasome Inhibitor, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Cholinergic Muscarinic Antagonist
Package NDCs
65

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Qilu Pharmaceutical Co., Ltd. NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
OlanzapineOlanzapine 10 mg/2mLInjection, Powder, For solutionIntramuscular67184-057367184-0573-01—
Nicardipine HydrochlorideNicardipine hydrochloride 2.5 mg/mLInjection, SolutionIntravenous67184-061167184-0611-02—
MirabegronMirabegron 25 mg/1Tablet, Film coated, Extended releaseOral67184-057167184-0571-0167184-0571-02—
MirabgeornmirabegronMirabegron 50 mg/1Tablet, Film coated, Extended releaseOral67184-057267184-0572-0167184-0572-02—
Ganirelix AcetateGanirelix acetate 250 ug/.5mLInjection, SolutionSubcutaneous67184-057467184-0574-01—
MicafunginMicafungin 10 mg/mLInjection, Powder, Lyophilized, For solutionIntravenous67184-058967184-0589-0167184-0589-02—
MicafunginMicafungin 20 mg/mLInjection, Powder, Lyophilized, For solutionIntravenous67184-059067184-0590-0167184-0590-02—
Icosapent EthylIcosapent ethyl 1 g/1CapsuleOral67184-058267184-0582-01—
BumetanideBumetanide .25 mg/mLInjectionIntramuscular, Intravenous67184-059367184-0593-02—
BumetanideBumetanide .25 mg/mLInjectionIntramuscular, Intravenous67184-059467184-0594-02—
Cetrorelix acetatecetrorelix acetate for injection—KitSubcutaneous67184-060567184-0605-02—
Amikacin SulfateAmikacin sulfate 250 mg/mLInjection, SolutionIntramuscular, Intravenous67184-056967184-0569-02—
Amikacin SulfateAmikacin sulfate 250 mg/mLInjection, SolutionIntramuscular, Intravenous67184-057067184-0570-02—
HydroxyureaHydroxyurea 500 mg/1CapsuleOral67184-060767184-0607-01—
Melphalan Hydrochloride—KitIntravenous67184-061867184-0618-02—
GefitinibGefitinib 250 mg/1Tablet, CoatedOral67184-053167184-0531-0167184-0531-0267184-0531-03—
imatinib mesylateImatinib mesylate 100 mg/1TabletOral67184-053267184-0532-0167184-0532-0267184-0532-03—
imatinib mesylateImatinib mesylate 400 mg/1TabletOral67184-053367184-0533-0167184-0533-0267184-0533-03—
Pemetrexedpemetrexed disodiumPemetrexed disodium hemipentahydrate 100 mg/4mLInjection, Powder, Lyophilized, For solutionIntravenous67184-050367184-0503-01—
Pemetrexedpemetrexed disodiumPemetrexed disodium hemipentahydrate 500 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenous67184-050467184-0504-01—
BortezomibBortezomib 3.5 mg/1Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous67184-0530——
TadalafilTadalafil 5 mg/1Tablet, Film coatedOral67184-052467184-0524-0167184-0524-02—
TadalafilTadalafil 10 mg/1Tablet, Film coatedOral67184-052567184-0525-02—
TadalafilTadalafil 20 mg/1Tablet, Film coatedOral67184-052667184-0526-0167184-0526-02—
TadalafilTadalafil 2.5 mg/1Tablet, Film coatedOral67184-052367184-0523-0167184-0523-02—
DaptomycinDaptomycin 500 mg/10mLInjection, Powder, Lyophilized, For solutionIntravenous67184-054967184-0549-01—
DecitabineDecitabine 50 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenous67184-053567184-0535-01—
Fosaprepitant DimeglumineFosaprepitant dimeglumine 150 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenous67184-054067184-0540-01—
Solifenacin Succinatesolifenacin succinate tabletsSolifenacin succinate 10 mg/1Tablet, Film coatedOral67184-051767184-0517-0167184-0517-0267184-0517-03+1 more—
Palonosetronpalonosetron hydrochloridePalonosetron hydrochloride .25 mg/5mLInjectionIntravenous67184-051467184-0514-01—
Palonosetronpalonosetron hydrochloridePalonosetron hydrochloride .075 mg/1.5mLInjectionIntravenous67184-051567184-0515-02—
Ceftriaxone SodiumCeftriaxone sodium 250 mg/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100567184-1005-0167184-1005-02J0696
Ceftriaxone SodiumCeftriaxone sodium 500 mg/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100667184-1006-0167184-1006-02J0696
Ceftriaxone SodiumCeftriaxone sodium 1 g/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100767184-1007-01J0696
Ceftriaxone SodiumCeftriaxone sodium 2 g/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100867184-1008-01J0696
OxaliplatinOxaliplatin 50 mg/10mLInjection, SolutionIntravenous67184-050867184-0508-01—
OxaliplatinOxaliplatin 100 mg/20mLInjection, SolutionIntravenous67184-050967184-0509-01—
OxaliplatinOxaliplatin 200 mg/40mLInjection, SolutionIntravenous67184-051067184-0510-01—
OxaliplatinOxaliplatin 50 mg/10mLInjection, Powder, Lyophilized, For solutionIntravenous67184-050167184-0501-01—
OxaliplatinOxaliplatin 100 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenous67184-050267184-0502-01—
Irinotecan HydrochlorideIrinotecan hydrochloride 20 mg/mLInjection, SolutionIntravenous67184-051167184-0511-01—
Irinotecan HydrochlorideIrinotecan hydrochloride 20 mg/mLInjection, SolutionIntravenous67184-051267184-0512-01—
Irinotecan HydrochlorideIrinotecan hydrochloride 20 mg/mLInjection, SolutionIntravenous67184-051367184-0513-01—
Cefepimecefepime hydrochlorideCefepime hydrochloride 500 mg/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100267184-1002-01—
Cefepimecefepime hydrochlorideCefepime hydrochloride 1 g/1Injection, Powder, For solutionIntramuscular, Intravenous67184-100367184-1003-01—
Cefepimecefepime hydrochlorideCefepime hydrochloride 2 g/1Injection, Powder, For solutionIntravenous67184-100467184-1004-01—
OlanzapineOlanzapine 2.5 mg/1TabletOral67184-0561——
OlanzapineOlanzapine 5 mg/1TabletOral67184-0562——
OlanzapineOlanzapine 7.5 mg/1TabletOral67184-0563——
OlanzapineOlanzapine 10 mg/1TabletOral67184-0564——

Qilu Pharmaceutical Co., Ltd.: common questions

What is Qilu Pharmaceutical Co., Ltd.'s NDC labeler code?
67184. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Qilu Pharmaceutical Co., Ltd.?
Med-Code's HCPCS directory matches J0696, J2405 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
Qilu Pharmaceutical Co., Ltd. NDC Codes | Med-Code